The Global Respiratory Syncytial Virus Therapeutics market is expected to grow from 2018 to 2026.

The key vendors mentioned are MEDIVIR AB, AstraZeneca plc., AbbVie, Inc., F. Hoffmann-La Roche Ltd., Gilead Sciences, Inc., Teva Pharmaceuticals Industries Ltd., Merck Co., Inc., GlaxoSmithKline plc., ReViral Ltd., and Valeant Pharmaceuticals International, Inc.

Hyderabad, India – October 9, 2019 /MarketersMedia/ —

Respiratory syncytial virus (RSV) is a common and contagious virus that infects the respiratory tract of children and adults. An RSV infection can lead to serious problems such as bronchiolitis and pneumonia. RSV is spread from respiratory secretions through close contact with infected persons. RSV does not usually occur until a baby is 4 to 6 week old. No specific approved drug or vaccine has been available to treat or prevent RSV infection to date. Factors such as Rise in prevalence of RSV infection among infants and the increasing interest of different biotechnology companies to develop various recombinant drugs to treat RSV infection are fuelling the market growth. However, the high price of prophylaxis drugs and a lack of return of investment in antiviral drugs are anticipated to restrict the market growth.

Access the complete report at: https://www.syngeneresearch.com/global-respiratory-syncytial-virus-therapeutics-market-analysis-2019-2/

By dosage form, the injectable segment is going to have a lucrative growth during the forecast period as it provides instant response to treat or prevent RSV infection. For example, AstraZeneca has developed a monoclonal antibody, called SYNAGIS, to prevent severe RSV infection, which is available in the injectable form. The advantage of this injection is that it instantly boosts the immune system to combat the infection.

Make an inquiry at: https://www.syngeneresearch.com/global-respiratory-syncytial-virus-therapeutics-market-analysis-2019-2/

Dosage Forms Covered:
• Injectable
• Oral
• Other Dosage Forms

Drugs Types Covered:
• Ribavirin
• Palivizumab
• Other Drugs Types

Distribution Channels Covered:
• Hospital Pharmacies
• Drug Stores
• Retail Pharmacies
• Other Distribution Channels

Regions Covered:
• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

Learn more about Syngeneresearch here: https://www.syngeneresearch.com/about-syngene-research/

Key Questions Answered in this Report:
• How this market evolved since the year 2016
• Market size estimations, forecasts and CAGR for all the segments presented in the scope
• Key Market Developments and financials of the key players
• Opportunity Analysis for the new entrants
• SWOT Analysis of the key players
• Fastest growing markets analysed during the forecast period

Contact Info:
Name: Sadhana Shukla
Email: Send Email
Organization: Syngene Market Research Reports
Website: https://www.syngeneresearch.com/

Source URL: https://marketersmedia.com/the-global-respiratory-syncytial-virus-therapeutics-market-is-expected-to-grow-from-2018-to-2026/88926727

Source: MarketersMedia

Release ID: 88926727